13
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Involvement of Arcuate Nucleus of Hypothalamus in the Descending Pathway from Nucleus Accumbens to Periaqueductal Grey Subserving an Antinociceptive Effect

&
Pages 71-78 | Received 30 Mar 1989, Published online: 07 Jul 2009
 

Abstract

The present study was performed to explore the possible involvement of the arcuate nucleus of hypothaia-mus (ARH) and β-endorphinergic pathway in the connection from nucleus accumbens to periaqueductal grey (PAG). It was found that the analgesic effect of morphine administered to nucleus accumbens of the rabbit was significantly attenuated by the antiserum against β-endorphin (β-EP) injected into PAG. the antagonistic effect was totally abolished by lesioning of the ARH. However, in the rabbit with ARH lesioning, no significant change in basal nociceptive threshold was seen nor was there any significant change in the efficacy of analgesia induced by injecting morphine into nucleus accumbens. the latter effect was attenuated by intra-PAG-administered naloxone, as in the normal control rabbits. These results indicate that (1) ARH and its efferent β-endorphinergic fibers are involved in the descending pathway from the nucleus accumbens to PAG, subserving an antinociceptive effect, (2) endogenous opioid peptides other thanβ-EP seem to play an equally important role in mediating analgesia.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.